Company Jiangsu Hengrui Medicine Co., Ltd.

Equities

600276

CNE0000014W7

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
46.21 CNY +0.65% Intraday chart for Jiangsu Hengrui Medicine Co., Ltd. +1.27% +2.17%

Business Summary

Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:

- anti-tumor drugs (No. 1 Chinese);

- Anesthetic drugs;

- contrast agents: used in medical imaging;

- anti-inflammatory drugs;

- drugs for the treatment of cardiovascular diseases.

Number of employees: 20,636

Sales per Business

CNY in Million2021Weight2022Weight Delta
Anti-tumor
53.2 %
13,072 50.5 % 11,313 53.2 % -13.45%
Others
18.0 %
4,523 17.5 % 3,836 18.0 % -15.19%
Anesthesia
15.7 %
4,916 19.0 % 3,336 15.7 % -32.15%
Contrast Agent
12.8 %
3,270 12.6 % 2,729 12.8 % -16.54%
Other Business
0.3 %
125 0.5 % 62 0.3 % -50.29%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
96.3 %
25,164 97.6 % 20,434 96.3 % -18.80%
Abroad
3.7 %
617 2.4 % 779 3.7 % +26.37%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 00-06-30
Director of Finance/CFO 47 21-11-18
Compliance Officer 32 21-05-31
Director/Board Member 63 23-02-01
Director/Board Member 49 04-12-31
Director/Board Member 63 10-08-05
Director/Board Member 54 97-12-31
Investor Relations Contact - -
Corporate Secretary 39 11-07-31
Corporate Officer/Principal 61 99-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 54 97-12-31
Chief Executive Officer 48 00-06-30
Chairman 66 03-02-28
Corporate Officer/Principal 61 99-12-31
Chairman - 86-12-31
Director/Board Member 63 10-08-05
Director/Board Member 49 04-12-31
Director/Board Member 63 23-02-01
Director/Board Member 52 20-01-15
Compliance Officer 32 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,379,002,274 3,258,210,645 ( 51.08 %) 20,442,448 ( 0.3205 %) 51.08 %

Shareholders

NameEquities%Valuation
1,538,184,187 24.16 % 9 118 M ¥
Tibet Dazi Dayuan Business Management Co. Ltd.
14.96 %
952,752,304 14.96 % 5 648 M ¥
China State-Owned Assets Supervision & Admn Commission
4.120 %
262,344,248 4.120 % 1 555 M ¥
Qingdao Bosentai Investment Partnership LP
2.870 %
182,756,856 2.870 % 1 083 M ¥
Zhong Ou Asset Management Co., Ltd
1.884 %
119,982,579 1.884 % 711 M ¥
Lianyungang Finance Holding Group Co. Ltd.
1.847 %
117,609,880 1.847 % 697 M ¥
China Securities Finance Corp. Ltd.
1.498 %
95,399,822 1.498 % 566 M ¥
China Asset Management Co., Ltd.
1.002 %
63,772,597 1.002 % 378 M ¥
China Investment Corp. (Investment Management)
0.9126 %
58,111,212 0.9126 % 344 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.8705 %
55,429,959 0.8705 % 329 M ¥

Holdings

NameEquities%Valuation
22,254,027 0.35% 131,916,976 $

Company contact information

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

7 Kunlunshan Road Economic & Technological Devt Zone

222000, Lianyungang

+

http://www.hengrui.com
address Jiangsu Hengrui Medicine Co., Ltd.(600276)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
45.91 CNY
Average target price
56.88 CNY
Spread / Average Target
+23.89%
Consensus